Red clover isoflavones in practice: A clinician's view

Journal of the British Menopause Society

Volumn 10, Issue SUPPL. 1, 2004, Pages 7-12

  Pitkin, Joan ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Isoflavones; Menopause; Red clover; Soy

Indexed keywords

ANTIBIOTIC AGENT; BIOCHANIN A; DAIDZEIN; ESTROGEN; FORMONONETIN; GENISTEIN; GESTAGEN; GONADORELIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IPRIFLAVONE; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PROTON PUMP INHIBITOR; RALOXIFENE; RED CLOVER EXTRACT; TAMOXIFEN; TIBOLONE;

ADULT; ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE DENSITY; BONE MINERAL; BREAST CANCER; CANCER RISK; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EXCRETION; DRUG RECEPTOR BINDING; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MAMMOGRAPHY; MENOPAUSAL SYNDROME; NIGHT SWEAT; OSTEOPENIA; POSTMENOPAUSE OSTEOPOROSIS; PREMATURE OVARIAN FAILURE; RED CLOVER; RISK BENEFIT ANALYSIS; SIDE EFFECT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URINARY EXCRETION; VASOMOTOR DISORDER; VENOUS THROMBOEMBOLISM;

FEMALE; GREAT BRITAIN; HOT FLASHES; HUMANS; MENOPAUSE; PHYSICIAN'S PRACTICE PATTERNS; PHYTOESTROGENS; PHYTOTHERAPY; PLANT PREPARATIONS; RANDOMIZED CONTROLLED TRIALS; TRIFOLIUM;

EID: 1942484399     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/136218004322986997     Document Type: Article

References (36)

1. Pitkin J. Compliance with estrogen replacement therapy: current issues. In Schneider HPG, ed. Menopause; the state of the art in research and management. The proceedings of the 10th world congress on the menopause, pp 430-437. London: Parthenon Publishing Group, 2002.
2. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333.
3. Collaborative Group on Hormonal Factors in Breast Cancer 1997. Breast Cancer and HRT: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997; 35: 1047-1059
4. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. The Women's Health Initiative randomized trial. JAMA 2003; 289: 3243-53.
5. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-427.
6. Garton M, and others. Breast cancer and hormone-replacement therapy: the Million Women Study. Lancet 2003; 362: 1328-31
7. Eisenberg D, David RB, Ettner SL, et al. Trends in alternative medicine use in the United States; 1990-1997. JAMA 1998; 280: 1569-1575.
8. Ernst E, White AR. The BBC survey of complementary medicine use in the UK. Complement Ther Med 2000; 8: 32-36.
9. Kass-Annese B. Alternative therapies for menopause. Clin Obstet Gynecol 2000;4 3: 1631-83.
10. Pitkin J, Tanna N. Pharmacy support for the clinician involved in menopause management ; a new model for Europe? Proceedings of European Menopause and Andropause Society, May 2003, Bucharest.
11. Bond M, Bywaters P. Towards understanding women's decisions to cease HRT. J Adv. Nurs 1999; 29: 852-858.
12. Kam IW, Dennehy CE, Tsourounis C. Dietary supplement use among menopausal women attending a San Francisco health conference. Menopause 2002; 9: 72-78
13. Albertazzi P, Steel SA, Clifford E, Bottazzi M. Attitudes towards and use of dietary supplementation in a sample of postmenopausal women. Climacteric 2002; 5: 374-382.
14. Mclennan A.H. The four harms of harmless therapies. Climacteric 1999; 2: 73-74.
15. Ernst E. Herbalism and the menopause. J Br Menopause Soc 2002; 8: 72-74.
16. Penotti M, Fabio E, Modena AB et al. Effect of soy-derived isoflavones on hot flushes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries. Fertil Steril 2003; 79: 1112-1117.
17. Nikander E, Kikkinen A, Metsa-Heikkila M et al. A randomised placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet.Gynecol 2003; 101: 1213-1220.
18. Jeri AR. The use of an isoflavones supplement to relieve hot flushes. The Female Patient 2002; 27: 35-37.
19. Nachtigall LB, Lagrega L, Nachtigall LE. The effect of isoflavone derived from red clover on vasomotor symptoms and endometrial thickness. Proceedings 81st Annual Meeting Us Endocrine Society 1999, San Diego.
20. Baber RJ, Templeman C, Morton T, et al. Randomized placebo-controlled trial of an isoflavones supplement and menopausal symptoms in women. Climacteric 1999; 2: 85-92.
21. Tice JA, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 2003; 290: 207-214.
22. Van Patten CL, Olivotto IA, Chambers GK, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol 2002; 20: 1449-1455.
23. Setchell KD, Brown N M, Desai P, et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial isoflavone supplements. J Nutr 2001; 131: S1362-1375.
24. Valente M, Bufalino L, Castiglione GN, et al. Effects of 1 year treatment with ipriflavone on bone on post menopausal women with low bone mass. Calcif Tissue Int. 1994; 54: 377-380.
25. Kuiper GG, Carlsson B, Grandien K et al. Comparison of the ligand binding specificity and transcript tissue distribution of oestrogen receptors alpha and beta. Endocrinology 1997; 138: 863-870.
26. Petrakis NL, Barnes S, King EB et al. Stimulatory influence of soy protein isolate on breast secretion in pre and post menopausal women. Cancer Epidemiol Biomarkers Prev 1996; 5: 785-794.
27. Hargreaves DF, Potten CS, Harding C, et al. Two-week dietary soy supplementation has an oestrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999; 84: 4017-4024.
28. Shu XO, Jin F, Dai O, et al. Soy food intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001; 10: 483-488.
29. Key TJ, Sharp GB, Appleby PN et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki. Br J Cancer 1999; 81: 1248-1256.
30. Gravelle IH, Bulbrook RD, Wang DY et al. A comparison of mammographic parenchymal patterns in premenopausal Japanese and British women. Breast Cancer Res Treat 1991; 18: S93-95.
31. Maskarinec G, Meng L. An investigation of soy intake and mammographic characteristics in Hawaii. Breast Cancer Res 2001; 3: 134-141.
32. Atkinson C, Warren RMLW, Dowsett M, et al. Effects of isoflavones on breast density, oestrodiol and gonadotrophins: a double blind randomised placebo controlled trial. Endocrine Society Annual Meeting; Program Abstracts (P2-652) 2001; 433.
33. Akiyama T, Oyawara H. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol 1991; 201: 362-370.
34. Constantinou A, Huberman E. Genistein as an inducer of tumour cell differentiation; possible mechanism of action. Proc Soc Exp Biol Med 1995; 208: 109-115.
35. Kim H, Peterson T.G, Barnes S. Mechanism of action of soy isoflavone genistein; emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr 1998; 68: S1418-1425.
36. Messina MJ, Loprinzi CL. Soy for breast cancer survivors; a critical review of the literature. J Nutr 2001; 131: S3095-3108.